Syneos Health Inc operates in the Commercial physical research sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Syneos Health Inc with three other
companies in this sector in the United States:
sales of $1.88 billion
of which 100%
was Drug Discovery & Development),
PRA Health Sciences Inc
of which 91%
was Clinical Research), and
Charles River Laboratories International Inc
of which 58%
was Discovery And Safety Assessment).
Syneos Health Inc reported sales of $4.39 billion
December of 2018.
increase of 64.3%
versus 2017, when the company's sales were $2.67 billion.
Sales at Syneos Health Inc have increased during each of the previous five years
(and since 2013, sales have increased a total of 341%).
Sales of Commercial Solutions saw an increase
that was more than double the company's growth rate: sales were up
200.1% in 2018, from
$392.88 million to $1.18 billion.